Target
C-C chemokine receptor type 2
Ligand
BDBM50363946
Substrate
n/a
Meas. Tech.
ChEMBL_802787 (CHEMBL1953521)
IC50
10.3±n/a nM
Citation
 Xue, CBFeng, HCao, GHuang, TGlenn, JAnand, RMeloni, DZhang, KKong, LWang, AZhang, YZheng, CXia, MChen, LTanaka, HHan, QRobinson, DJModi, DStorace, LShao, LSharief, VLi, MGalya, LGCovington, MScherle, PDiamond, SEmm, TYeleswaram, SContel, NVaddi, KNewton, RHollis, GFriedman, SMetcalf, B Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist. ACS Med Chem Lett 2:450-454 (2011) [PubMed]  Article 
Target
Name:
C-C chemokine receptor type 2
Synonyms:
C-C chemokine receptor type 2 (CCR2) | CCR2 | CCR2_HUMAN | CMKBR2 | Chemoattractant Cytokine Receptor 2 (CCR2) | Chemokine Receptor Type 2b (CCR2b) | Monocyte chemotactic protein-1 (MCP-1)
Type:
Enzyme
Mol. Mass.:
41932.32
Organism:
Homo sapiens (Human)
Description:
P41597
Residue:
374
Sequence:
MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA
  
Inhibitor
Name:
BDBM50363946
Synonyms:
CHEMBL1951771
Type:
Small organic molecule
Emp. Form.:
C24H28F3N5O3
Mol. Mass.:
491.506
SMILES:
O[C@]1(CC[C@@H](CC1)N1CC[C@H](C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ncccn1 |r,wU:4.7,wD:10.13,1.0,(-5.61,-27.39,;-4.83,-28.74,;-4.02,-30.05,;-2.49,-30.02,;-1.74,-28.67,;-2.54,-27.35,;-4.09,-27.38,;-.2,-28.64,;.72,-29.87,;2.17,-29.36,;2.14,-27.82,;.67,-27.38,;3.47,-27.04,;4.81,-27.79,;4.83,-29.33,;6.14,-27,;7.48,-27.76,;8.8,-26.97,;8.78,-25.43,;10.15,-27.72,;10.16,-29.26,;11.5,-30.02,;12.82,-29.23,;12.8,-27.68,;11.46,-26.93,;14.12,-26.89,;15.47,-27.64,;14.1,-25.35,;15.45,-26.11,;-6.37,-28.77,;-7.17,-27.46,;-8.71,-27.49,;-9.45,-28.84,;-8.66,-30.16,;-7.11,-30.13,)|
Structure:
Search PDB for entries with ligand similarity: